Global Ganja Report

Officials in Mendocino County revealed Jan. 11 that the US Attorney's Office in San Francisco had threatened to sue the county over its medical marijuana cultivation permit program, prompting its suspension. The warning was delivered at a Jan. 3 meeting between County Counsel Jeanine Nadel and representatives of the US Attorney's Office, Nadel said. County supervisors are scheduled to review the permit ordinance on Jan. 24. The program was also suspended pending the outcome of a Southern California court case that tests the legitimacy of issuing permits for cannabis-related endeavors—the reason given by officials at the time of the suspension on Jan 9.

Mendocino County's unique income-generating medical marijuana cultivation permit process has been suspended, officials announced Jan. 9. The decision was made in light of a Southern California court case that challenges the legality of issuing permits for activities that are illegal under federal law.

Moderate cannabis use appears to cause no long-term damage to the lungs, according to a new study by the University of California at San Francisco and the University of Alabama at Birmingham, released Jan. 10 in the Journal of the American Medical Association. Results of the 20-year study, funded by the National Institute on Drug Abuse, indicate that cannabis doesn't do the kind of damage tobacco does.

Long the main gateway to Europe for Moroccan hashish, Spain has over the past year emerged as one of the continent's main cannabis cultivation hubs, rivaling the Netherlands. Principal cultivation zones are Andalusia, Murcia, Catalonia, Aragon and especially Valencia—which the Guardia Civil describes as "a jungle of cannabis."

A British study discounts a link between occasional cannabis smoking or other light illicit drug use and the decline in mental functions that comes with middle age. The study, carried in the American Journal of Epidemiology, tested the mental function and memory of nearly 9,000 Britons at age 50 and found that those who had used illegal drugs as recently as in their 40s did just as well on the tests as peers who had never used drugs—or slightly better.

A federal judge on Jan. 4 granted an American Civil Liberties Union (ACLU) request to throw out a lawsuit filed by Arizona Gov. Jan Brewer seeking to strike down the state's voter-approved medical marijuana law. Filed in May, Brewer's suit argued that state officials could face federal prosecution for implementing the law—despite Arizona's then-US Attorney Dennis Burke stating publicly that the federal government has "no intention of targeting or going after people who are implementing or who are in compliance with state law." In throwing out the suit, US District Court Judge Susan R. Bolton said there is no genuine threat of imminent federal prosecution of state officials who carry out the law.

A new study postulates a link between states with legalized medical marijuana and a reduction in traffic-related fatalities. The study was conducted by D. Mark Anderson, a Montana State University economics professor, and Daniel Rees, of the University of Colorado Denver. In looking at state-level data from sources such as the National Survey on Drug Use and Health, Anderson and Rees found that states with medical marijuana laws saw an average 9% decrease in traffic deaths. "We were pretty surprised that they went down," Rees told the Denver Post.

We recently reported claims that the DEA has granted unnamed private pharmaceutical companies license to grow cannabis for experimental purposes. Now, the Sacramento News & Review on Dec. 19 cites a report from the Union of Medical Marijuana Patients to the effect that the United States government holds a patent on the use of cannabinoids as "antioxidants and neuroprotectants"—specifically, the Department of Health & Human Services holds Patent #6630507, as documented at the US Patent & Trademark Office.